Atypical symptomatology of myoclonus dystonia (DYT-11) with positive response to bilateral pallidal deep brain stimulation

Movement Disorders

Volumn 29, Issue 7, 2014, Pages

  Papuć, Ewa ^a   Obszańska, Katarzyna ^a   Rejdak, Konrad ^a   Stelmasiak, Zbigniew ^a   Trojanowski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CLONAZEPAM; LEVODOPA;

ADULT; BRAIN DEPTH STIMULATION; CASE REPORT; DETERIORATION; GENETIC SCREENING; GLOBUS PALLIDUS; HUMAN; LEG DISEASE; LETTER; MYOCLONUS DYSTONIA; PRIORITY JOURNAL; SCORING SYSTEM; DYSTONIC DISORDERS; MALE; MYOCLONUS; TREATMENT OUTCOME;

ADULT; DEEP BRAIN STIMULATION; DYSTONIC DISORDERS; HUMANS; MALE; MYOCLONUS; TREATMENT OUTCOME;

EID: 84902268718     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23783     Document Type: Letter

References (7)

1. Gasser T. Inherited myoclonus-dystonia syndrome. Adv Neurol 1998;78:325-334.
2. Asmus F, Zimprich A, Tezenas Du Montcel S, et al. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 2002;52:489-492.
3. Asmus F, Gasser T. Dystonia-plus syndromes. Eur J Neurol 2010;17(Suppl 1):37-45.
4. Volkman J, Benecke R. Deep brain stimulation for dystonia: patient selection and evaluation. Mov Disord 2002;17(Suppl 3):S112-S115.
5. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol 1998;78:1-10.
6. Hjermind LE, Werdelin LM, Eiberg H, Krag-Olsen B, Dupont E, Sorensen SA. A novel mutation in the ε-sarcoglycan gene causing myoclonus-dystonia syndrome. Neurology 2003;60:1536-1539.
7. Speelman JD, Contarino MF, Schuuurman PR, Tijssen AJ, Bie RM. Deep brain stimulation for dystonia: patient selection and outcomes. Eur J Neurol 2010;17(Suppl 1):102-106.